Clinical Trial Update: Perioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for perioperative encobini in BRAFV600-mutant melanoma with stage III/oligometastatic stage IV disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Encobini (Encobini)

Snippet

Sponsor: CCTU- Cancer Theme | Conditions: Melanoma, Cancer | Phase 2 | Status: UNKNOWN